| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Replimune Group, Inc. | Director | Stock Option (right to buy) | 32K | Apr 1, 2024 | Direct | ||
| Coya Therapeutics, Inc. | Director | Stock Option (right to buy) | 5K | Jan 1, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| REPL | Replimune Group, Inc. | Apr 1, 2024 | 1 | $0 | 4 | Apr 3, 2024 | Director |
| COYA | Coya Therapeutics, Inc. | Jan 1, 2024 | 1 | $0 | 4 | Jan 19, 2024 | Director |
| COYA | Coya Therapeutics, Inc. | Aug 18, 2023 | 1 | $0 | 4 | Aug 21, 2023 | Director |
| COYA | Coya Therapeutics, Inc. | Aug 18, 2023 | 0 | $0 | 3 | Aug 21, 2023 | Director |
| REPL | Replimune Group, Inc. | Apr 1, 2023 | 1 | $0 | 4 | Apr 4, 2023 | Director |
| REPL | Replimune Group, Inc. | Apr 1, 2022 | 1 | $0 | 4 | Apr 5, 2022 | Director |